A novel strategy based on a ligand-switchable nanoparticle delivery system for deep tumor penetration

• DOI: 10.1039/c8nh00415c
• Publication Date: 2018-12-20T10:34:52Z
• Authors: Yuxun Ding; Jinjian Liu; Yumin Zhang; Xue Li; Hanlin Ou; Tangjian Cheng; Lin Ma; Yingli An; Jianfeng Liu; Fan Huang; Yang Liu; Linqi Shi
• Keywords: 01 natural sciences; 0104 chemical sciences

The ligand-switchable nanocarriers (LSNs) concealed CPPs into the bloodstream and expose them upon entering into the tumor sites, and overall improving the therapeutic effect.